Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Yanamandra

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Molecular Biology|November 17, 2009
Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular propertiesMantas Malisauskas, Christoph Weise, Kiran Yanamandra, et al.
Cells|August 29, 2020
Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot StudySatoshi Muraoka, Mark P Jedrychowski, Kiran Yanamandra, et al.
Plos One|May 5, 2011
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patientsKiran Yanamandra, Marina A Gruden, Vida Casaite, et al.
Annals of Clinical and Translational Neurology|March 28, 2015
Anti-tau antibody reduces insoluble tau and decreases brain atrophyKiran Yanamandra, Hong Jiang, Thomas E Mahan, et al.
The Journal of Biological Chemistry|October 19, 2012
S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregationHugo M Botelho, Sónia S Leal, Isabel Cardoso, et al.
Journal of Molecular Biology|December 1, 2006
Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathwaysAnna L Gharibyan, Vladimir Zamotin, Kiran Yanamandra, et al.
Behavioural Brain Research|January 22, 2013
Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamineMarina A Gruden, Tatiana V Davidova, Kiran Yanamandra, et al.
Neuroimmunomodulation|September 19, 2012
Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammationMarina A Gruden, Kiran Yanamandra, Valery G Kucheryanu, et al.
Neuron|October 1, 2013
Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivoKiran Yanamandra, Najla Kfoury, Hong Jiang, et al.
Iscience|January 24, 2022
Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding modelJustine D Manos, Christina N Preiss, Nandini Venkat, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Molecular Biology|November 17, 2009
Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular propertiesMantas Malisauskas, Christoph Weise, Kiran Yanamandra, et al.
Cells|August 29, 2020
Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot StudySatoshi Muraoka, Mark P Jedrychowski, Kiran Yanamandra, et al.
Plos One|May 5, 2011
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patientsKiran Yanamandra, Marina A Gruden, Vida Casaite, et al.
Annals of Clinical and Translational Neurology|March 28, 2015
Anti-tau antibody reduces insoluble tau and decreases brain atrophyKiran Yanamandra, Hong Jiang, Thomas E Mahan, et al.
The Journal of Biological Chemistry|October 19, 2012
S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregationHugo M Botelho, Sónia S Leal, Isabel Cardoso, et al.
Journal of Molecular Biology|December 1, 2006
Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathwaysAnna L Gharibyan, Vladimir Zamotin, Kiran Yanamandra, et al.
Behavioural Brain Research|January 22, 2013
Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamineMarina A Gruden, Tatiana V Davidova, Kiran Yanamandra, et al.
Neuroimmunomodulation|September 19, 2012
Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammationMarina A Gruden, Kiran Yanamandra, Valery G Kucheryanu, et al.
Neuron|October 1, 2013
Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivoKiran Yanamandra, Najla Kfoury, Hong Jiang, et al.
Iscience|January 24, 2022
Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding modelJustine D Manos, Christina N Preiss, Nandini Venkat, et al.
Pageof 2